Vertex Refuses To Back Down On England Orkambi Deal

Vertex is staunchly defending its cystic fibrosis portfolio-based reimbursement deal rejected by NHS England and has called on the UK’s prime minister to intervene. The company says similar deals have worked well in Ireland and Sweden.

Business
Orkambi Talks Between Vertex and NHS England Break Down • Source: Shutterstock

More from Europe

More from Geography